Insider activity at Amicus Therapeutics, Inc. has been all selling for a year now: about $5.4 million from four sellers, and zero buyers with their own money.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Campbell Bradley L | CEO | Sell | 22,500 | $14.35 | $323K | SEC |
| Jan 22, 2026 | Campbell Bradley L | CEO | Sell | 75,000 | $14.31 | $1.1M | SEC |
| Dec 23, 2025 | Clark David Michael | Executive Officer | Sell | 25,642 | $14.17 | $363K | SEC |
| Dec 17, 2025 | Campbell Bradley L | CEO | Sell | 77,926 | $10.86 | $846K | SEC |
| Dec 17, 2025 | Clark David Michael | Executive Officer | Sell | 25,643 | $11.00 | $282K | SEC |
| Dec 3, 2025 | Campbell Bradley L | CEO | Sell | 14,587 | $10.01 | $146K | SEC |
| Nov 26, 2025 | Castelli Jeff | Executive Officer | Sell | 76,158 | $10.16 | $774K | SEC |
| Nov 26, 2025 | Clark David Michael | Executive Officer | Sell | 25,643 | $10.10 | $259K | SEC |
| Nov 26, 2025 | Campbell Bradley L | CEO | Sell | 14,587 | $10.04 | $146K | SEC |
| Nov 26, 2025 | Rosenberg Ellen | Executive Officer | Sell | 36,000 | $10.00 | $360K | SEC |
| Nov 26, 2025 | Rosenberg Ellen | Executive Officer | Sell | 36,000 | $10.06 | $362K | SEC |
| Nov 26, 2025 | Rosenberg Ellen | Executive Officer | Sell | 23,621 | $10.00 | $236K | SEC |
| Nov 5, 2025 | Clark David Michael | Executive Officer | Sell | 25,643 | $9.51 | $244K | SEC |
| Feb 21, 2025 | Campbell Bradley L | CEO | Sell | 400 | $10.00 | $4K | SEC |
| Dec 3, 2024 | Campbell Bradley L | CEO | Sell | 7,500 | $10.02 | $75K | SEC |
In the last 12 months Amicus Therapeutics, Inc. insiders made open-market purchases worth about $0 and sales worth about $5.4 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in FOLD was filed on 2026-03-04.
No congressional trades in FOLD were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).